{"AllianceGenome": "9603", "HGNC": "9603", "MIM": "601699", "_id": "5740", "_version": 1, "accession": {"genomic": ["AL118525.17", "BX640942.1", "CH471077.2", "CP068258.2", "D83402.2", "D84124.2", "HF583505.1", "NC_000020.11", "NC_060944.1", "NG_007940.1"], "protein": ["AAG31781.1", "AAG31782.1", "AAG31783.1", "AAG31784.1", "AAG31785.1", "AAI01810.1", "AAI01812.1", "BAA07343.1", "BAA11910.1", "BAA28219.1", "CCQ43002.1", "EAW75655.1", "NP_000952.1", "Q16647.1", "XP_047296281.1", "XP_054179732.1"], "rna": ["AF297048.1", "AF297049.1", "AF297050.1", "AF297051.1", "AF297052.1", "AK055640.1", "BC101809.1", "BC101811.1", "BC143381.1", "D38145.1", "NM_000961.4", "XM_047440325.1", "XM_054323757.1"], "translation": [{"protein": "BAA07343.1", "rna": "D38145.1"}, {"protein": "NP_000952.1", "rna": "NM_000961.4"}, {"protein": "AAI01810.1", "rna": "BC101809.1"}, {"protein": "AAG31781.1", "rna": "AF297048.1"}, {"protein": "AAI01812.1", "rna": "BC101811.1"}, {"protein": "AAG31782.1", "rna": "AF297049.1"}, {"protein": "AAG31785.1", "rna": "AF297052.1"}, {"protein": "XP_054179732.1", "rna": "XM_054323757.1"}, {"protein": "XP_047296281.1", "rna": "XM_047440325.1"}, {"protein": "AAG31783.1", "rna": "AF297050.1"}, {"protein": "AAG31784.1", "rna": "AF297051.1"}]}, "alias": ["CYP8", "CYP8A1", "PGIS", "PTGI"], "ec": ["4.2.1.152", "5.3.99.4"], "ensembl": {"gene": "ENSG00000124212", "protein": "ENSP00000244043", "transcript": ["ENST00000244043", "ENST00000478971"], "translation": [{"protein": "ENSP00000244043", "rna": "ENST00000244043"}], "type_of_gene": "protein_coding"}, "entrezgene": "5740", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 17.1847344008, "exp_mis": 193.862009833, "exp_syn": 89.6195488864, "lof_z": 1.71683686726197, "mis_z": -0.60204676629643, "mu_lof": 1.25687819775e-06, "mu_mis": 1.88049674469e-05, "mu_syn": 8.47671812592e-06, "n_lof": 10.0, "n_mis": 211.0, "n_syn": 82.0, "p_li": 2.42325399858621e-05, "p_null": 0.0843818697286842, "p_rec": 0.91559389773133, "syn_z": 0.498973416045863}, "bp": 1503, "cds_end": 48184653, "cds_start": 48124456, "n_exons": 10, "nonpsych": {"exp_lof": 15.3703217604, "exp_mis": 175.280310338, "exp_syn": 80.9308207296, "lof_z": 1.59577576577577, "mis_z": -0.751268886668729, "mu_lof": 1.25687819775e-06, "mu_mis": 1.88049674469e-05, "mu_syn": 8.47671812592e-06, "n_lof": 9.0, "n_mis": 195.0, "n_syn": 77.0, "p_li": 7.18460688880955e-05, "p_null": 0.101890602494964, "p_rec": 0.898037551436148, "syn_z": 0.275099413688182}, "nontcga": {"exp_lof": 15.7920677516, "exp_mis": 178.335173461, "exp_syn": 82.4321020704, "lof_z": 1.43778983648082, "mis_z": -0.547101829323985, "mu_lof": 1.25687819775e-06, "mu_mis": 1.88049674469e-05, "mu_syn": 8.47671812592e-06, "n_lof": 10.0, "n_mis": 193.0, "n_syn": 77.0, "p_li": 1.38390827477066e-05, "p_null": 0.154870290115078, "p_rec": 0.845115870802174, "syn_z": 0.378827810024946}, "transcript": "ENST00000244043.4"}, "exons": [{"cdsend": 49568116, "cdsstart": 49507919, "chr": "20", "position": [[49503873, 49508064], [49511027, 49511179], [49513079, 49513261], [49514226, 49514395], [49524057, 49524239], [49539569, 49539721], [49544304, 49544448], [49547840, 49548019], [49550065, 49550189], [49568042, 49568137]], "strand": -1, "transcript": "NM_000961", "txend": 49568137, "txstart": 49503873}], "exons_hg19": [{"cdsend": 48184653, "cdsstart": 48124456, "chr": "20", "position": [[48120410, 48124601], [48127564, 48127716], [48129616, 48129798], [48130763, 48130932], [48140594, 48140776], [48156106, 48156258], [48160841, 48160985], [48164377, 48164556], [48166602, 48166726], [48184579, 48184674]], "strand": -1, "transcript": "NM_000961", "txend": 48184674, "txstart": 48120410}], "generif": [{"pubmed": 11130769, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11368458, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11924728, "text": "Association study between a novel single nucleotide polymorphism of the promoter region of the prostacyclin synthase gene and essential hypertension."}, {"pubmed": 11924728, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12040339, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12193162, "text": "NMR and circular dichroism solution structure of microsomal PGIS"}, {"pubmed": 12213900, "text": "the fallopian tube expresses both COX isoforms and PGIS"}, {"pubmed": 12372404, "text": "the PGIS gene has a splicing mutation in familial hypertension"}, {"pubmed": 12414894, "text": "Cyclic mechanical stretch augmented prostacyclin synthase promoter activity, via activation of activator protein-1 site, and prostacyclin synthase mRNA and protein expression in cultured human myometrial cells"}, {"pubmed": 12414902, "text": "gestational age decrease in the inhibitory prostaglandin I2 synthase is consistent with lessening of its influence in myometrium at the time of labor"}, {"pubmed": 12428676, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12664597, "text": "effect of overexpression of this enzyme transfected into vascular smooth muscle cells in rats"}, {"pubmed": 12741817, "text": "residue(s) within helix F/G loop of PGIS may be involved in forming the substrate access channel and located in a position that influences the membrane-bound PGIS catalytic function"}, {"pubmed": 12751759, "text": "splicing mutation found in hypertension"}, {"pubmed": 12924623, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12924623, "text": "We successfully identified haplotypes of the PGIS gene, and these haplotypes were not associated with essential hypertension."}, {"pubmed": 15182267, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15182267, "text": "results suggest specific VNTR polymorphism in the 5'-upstream promoter region of the PGIS gene regulated prostacyclin production, but did not seem to be associated with development of CTEPH (chronic thromboembolic pulmonary hypertension)"}, {"pubmed": 16007128, "text": "Epigenetic inactivation of the PTGIS gene is a recurrent alteration in colorectal carcinogenesis"}, {"pubmed": 16081819, "text": "The two major genetic loci Pgis1 and Pgis2 of murine spondylitis are homologous to chromosome regions in human genome, which control ankylosing spondylitis in human patients."}, {"pubmed": 16406803, "text": "PGIS has a typical low-spin heme with a hydrophobic active site."}, {"pubmed": 16537708, "text": "Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17070428, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 17210107, "text": "Dengue virus could promote the expression of PGIS mRNA in HUVEC and increase the level of PGI(2), which may increase the vascular permeability."}, {"pubmed": 17221326, "text": "In vitro shear stress can promote PGI(2 )secretion by human endothelial progenitor cells."}, {"pubmed": 17303142, "text": "Adenovirus PGIS gene transfer reduced PPAR delta expression and inhibited neointimal formation after balloon injury in accordance with the reduction in the phosphorylation of p38 MAPK"}, {"pubmed": 17374734, "text": "PGIS promoter haplotype can play an important role in the predisposition for lung cancer and CpG methylation provides an epigenetic mechanism for the down-regulated PGIS expression."}, {"pubmed": 17635855, "text": "An intramuscular injection of AAV-PGIS prevents monocrotaline-pulmonary arterial hypertension in rats and provides a new therapeutic alternative for preventing pulmonary arterial hypertension in humans."}, {"pubmed": 18081314, "text": "These studies have provided the structural information for the interaction of the PGIS with its substrate mimic."}, {"pubmed": 18814254, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19040046, "text": "Populations with both COX-2 -765GG and PGIS CC genotypes were more at risk for myocardial infarction."}, {"pubmed": 19046748, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19046748, "text": "PTGIS genetic variation is associated with incident myocardial infarction. Carriers of rs20417C allele may derive greater benefits from aspirin use."}, {"pubmed": 19056482, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19064572, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19065539, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19065539, "text": "The CC genotype and C allele of the prostacyclin synthase gene might be a risk factor of MI in Uigur population in Xinjiang."}, {"pubmed": 19124506, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19147528, "text": "MI is associated with the CC genotype of rs5629 in the human CYP8A1 gene. The A-C-T haplotype appears to be a useful genetic marker and the C-T-T haplotype might be a protective factor of MI in Chinese people."}, {"pubmed": 19147528, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19187034, "text": "Characterization of the recombinant PGIS intermediates is reported in reactions with other peroxides, peracetic acid, and iodosylbenzene, providing a mechanistic model of a peroxidase reaction catalyzed by the class III cytochromes P450."}, {"pubmed": 19265782, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19265782, "text": "rs237484 is in proximity to the potassium voltage gate channel gene (KCNB1) and close to the prostaglandin I2 (prostacyclin) synthase gene (PTGIS)."}, {"pubmed": 19276290, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19327107, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19327107, "text": "The CC genotype of CYP8A1 is associated with myocardial infarction(MI), respectively."}, {"pubmed": 19336370, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19534932, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19578796, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19719985, "text": "In the Uigur population CC genotype of rs5629 and the C-T-T haplotype of prostacyclin synthase gene are associated with myocardial infarction but the A-C-T haplotype of prostacyclin synthase gene might be a protective factor."}, {"pubmed": 19719985, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19789190, "text": "Observational study of gene-disease association, gene-gene interaction, and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20159982, "text": "PGIS overexpression apparently protects insulin-producing cells against cytokine toxicity via suppression of endoplasmic reticulum and mitochondrial stress-mediated cell death pathways"}, {"pubmed": 20346360, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20348234, "text": "diabetes preferentially increases PGIS nitration that is associated with excessive vascular inflammation in atherosclerotic carotid arteries from patients with type 2 diabetes"}, {"pubmed": 20357747, "text": "Review: PGI2 function depends on the different alleles of the PTGIS gene and that they may influence the risk of cardiovascular disease."}, {"pubmed": 20452033, "text": "downregulated in endometriosis tissues"}, {"pubmed": 20453000, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 21052031, "text": "Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 22072641, "text": "The CC genotype of C1117A polymorphism is associated with higher risk of LM-CAD"}, {"pubmed": 22109564, "text": "Overexpression of PTGIS is associated with liver metastasis in colon cancer."}, {"pubmed": 22219064, "text": "High PTGIS expression is associated with colorectal cancer hepatic metastasis."}, {"pubmed": 23807031, "text": "These findings suggest that PGIS is induced by hypoxia and regulates the expression of VEGF in fibroblasts."}, {"pubmed": 24225501, "text": "Type-2 diabetes is associated with higher COX-2 expression, but lower eNOS and PGIS expression in subcutaneous arteries."}, {"pubmed": 24605778, "text": "In a case-control study unaffected carriers of a BMPR2 mutation, linked to pulmonary artery hypertension (PAH), were most often found to have prostacyclin synthase promoter sequence variants, which were thought to protect against PAH."}, {"pubmed": 25256272, "text": "results indicate that PGIS expression was associated with radiotherapy efficiency"}, {"pubmed": 25623425, "text": "Based on the predicted crystal structure of CYP8A1( *)5 using the Molecular Operating Environment platform, the distance from CYP8A1 Cys441 to the heme was altered with a significantly changed binding free energy for the mutant protein."}, {"pubmed": 26130461, "text": "In examining the tumor suppressor PTGIS as a potential biomarker for treatment with either 5-Aza-dC or TSA, 5-Aza-dC effectively stabilized cell cycling, restricted genetic instability and derepressed PTGIS expression"}, {"pubmed": 28852049, "text": "We identified an association between a PGIS variant and SAB risk that is modified by NSAIDs use during pregnancy and directly associated with increased levels of PGE metabolites. This suggests the potential use of genetic information to guide pharmaceutical intervention to prevent adverse pregnancy outcomes."}, {"pubmed": 32236489, "text": "Association of Rare PTGIS Variants With Susceptibility and Pulmonary Vascular Response in Patients With Idiopathic Pulmonary Arterial Hypertension."}, {"pubmed": 32559633, "text": "Derivation of an induced pluripotent stem cell line (PUMCHi003-A) from a patient with pulmonary arterial hypertension carrying heterozygous mutation in PTGIS gene."}, {"pubmed": 33527589, "text": "A new insight into subinteractomes of functional antagonists: Thromboxane (CYP5A1) and prostacyclin (CYP8A1) synthases."}, {"pubmed": 34155103, "text": "Reduced levels of prostaglandin I2 synthase: a distinctive feature of the cancer-free trichothiodystrophy."}, {"pubmed": 36703911, "text": "Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma."}, {"pubmed": 37258478, "text": "rRNA-Derived Small RNA rsRNA-28S Regulates the Chemoresistance of Prostate Cancer Cells by Targeting PTGIS."}, {"pubmed": 37779109, "text": "Validating the role of PTGIS gene in colorectal cancer by bioinformatics analysis and in vitro experiments."}, {"pubmed": 37796199, "text": "Analysis and experimental validation of fatty acid metabolism-related genes prostacyclin synthase (PTGIS) in endometrial cancer."}, {"pubmed": 38639351, "text": "Identification of Prostaglandin I2 Synthase Rare Variants in Patients With Williams Syndrome and Severe Peripheral Pulmonary Stenosis."}], "genomic_pos": {"chr": "20", "end": 49568137, "ensemblgene": "ENSG00000124212", "start": 49503874, "strand": -1}, "genomic_pos_hg19": {"chr": "20", "end": 48184683, "start": 48120411, "strand": -1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0001516", "qualifier": "involved_in", "term": "prostaglandin biosynthetic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0001516", "pubmed": [15115769, 20122998, 21296955], "qualifier": "involved_in", "term": "prostaglandin biosynthetic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006690", "pubmed": 15115769, "qualifier": "involved_in", "term": "icosanoid metabolic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006690", "qualifier": "involved_in", "term": "icosanoid metabolic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0019371", "qualifier": "involved_in", "term": "cyclooxygenase pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032088", "pubmed": 20159982, "qualifier": "involved_in", "term": "negative regulation of NF-kappaB transcription factor activity"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0034356", "qualifier": "involved_in", "term": "NAD biosynthesis via nicotinamide riboside salvage pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035360", "pubmed": 11551955, "qualifier": "involved_in", "term": "positive regulation of peroxisome proliferator activated receptor signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045019", "pubmed": 20159982, "qualifier": "involved_in", "term": "negative regulation of nitric oxide biosynthetic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045766", "pubmed": 20122998, "qualifier": "involved_in", "term": "positive regulation of angiogenesis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0050728", "pubmed": 20159982, "qualifier": "involved_in", "term": "negative regulation of inflammatory response"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0071347", "pubmed": 8185632, "qualifier": "involved_in", "term": "cellular response to interleukin-1"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0071354", "pubmed": 8185632, "qualifier": "involved_in", "term": "cellular response to interleukin-6"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0071456", "pubmed": 21296955, "qualifier": "involved_in", "term": "cellular response to hypoxia"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0097190", "pubmed": 11551955, "qualifier": "involved_in", "term": "apoptotic signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1900119", "pubmed": 11551955, "qualifier": "involved_in", "term": "positive regulation of execution phase of apoptosis"}], "CC": [{"evidence": "ISS", "gocategory": "CC", "id": "GO:0005615", "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": 21035466, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005783", "pubmed": 21035466, "qualifier": "located_in", "term": "endoplasmic reticulum"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005789", "qualifier": "located_in", "term": "endoplasmic reticulum membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005789", "qualifier": "located_in", "term": "endoplasmic reticulum membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005901", "pubmed": 20122998, "qualifier": "located_in", "term": "caveola"}], "MF": [{"category": "MF", "evidence": "IEA", "id": "GO:0004497", "qualifier": "enables", "term": "monooxygenase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005506", "qualifier": "enables", "term": "iron ion binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 20122998, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0008116", "qualifier": "enables", "term": "prostaglandin-I synthase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008116", "pubmed": [15115769, 20122998, 21296955], "qualifier": "enables", "term": "prostaglandin-I synthase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0008116", "qualifier": "enables", "term": "prostaglandin-I synthase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0016705", "qualifier": "enables", "term": "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen"}, {"category": "MF", "evidence": "IDA", "id": "GO:0020037", "pubmed": [17020766, 18032380], "qualifier": "enables", "term": "heme binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0106256", "qualifier": "enables", "term": "hydroperoxy icosatetraenoate dehydratase activity"}]}, "homologene": {"genes": [[7955, 559148], [8364, 100492372], [9544, 703407], [9598, 458323], [9606, 5740], [9615, 100856661], [9913, 282021], [10090, 19223], [10116, 25527]], "id": 37374}, "interpro": [{"desc": "Cytochrome P450", "id": "IPR001128", "short_desc": "Cyt_P450"}, {"desc": "Cytochrome P450, E-class, group IV", "id": "IPR002403", "short_desc": "Cyt_P450_E_grp-IV"}, {"desc": "Cytochrome P450, cholesterol 7-alpha-monooxygenase-type", "id": "IPR024204", "short_desc": "Cyt_P450_CYP7A1-type"}, {"desc": "Prostacyclin synthase", "id": "IPR027286", "short_desc": "PTGIS"}, {"desc": "Cytochrome P450 superfamily", "id": "IPR036396", "short_desc": "Cyt_P450_sf"}], "ipi": "IPI00003411", "map_location": "20q13.13", "name": "prostaglandin I2 synthase", "other_names": ["cytochrome P450, family 8, subfamily A, polypeptide 1", "hydroperoxy icosatetraenoate dehydratase", "prostacyclin synthase", "prostaglandin I2 (prostacyclin) synthase"], "pantherdb": {"HGNC": "9603", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1097156", "ortholog_type": "LDO", "panther_family": "PTHR24306", "taxid": 10090, "uniprot_kb": "O35074"}, {"Ensembl": "ENSRNOG00000008245", "ortholog_type": "O", "panther_family": "PTHR24306", "taxid": 10116, "uniprot_kb": "A0A0G2K776"}, {"RGD": "3438", "ortholog_type": "LDO", "panther_family": "PTHR24306", "taxid": 10116, "uniprot_kb": "Q62969"}, {"ZFIN": "ZDB-GENE-070116-1", "ortholog_type": "LDO", "panther_family": "PTHR24306", "taxid": 7955, "uniprot_kb": "F1RE08"}], "uniprot_kb": "Q16647"}, "pathway": {"biocarta": {"id": "eicosanoidpathway", "name": "eicosanoid metabolism"}, "humancyc": {"id": "PWY66-374", "name": "C20 prostanoid biosynthesis"}, "kegg": {"id": "hsa00590", "name": "Arachidonic acid metabolism - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-196807", "name": "Nicotinate metabolism"}, {"id": "R-HSA-196849", "name": "Metabolism of water-soluble vitamins and cofactors"}, {"id": "R-HSA-196854", "name": "Metabolism of vitamins and cofactors"}, {"id": "R-HSA-197264", "name": "Nicotinamide salvaging"}, {"id": "R-HSA-211859", "name": "Biological oxidations"}, {"id": "R-HSA-211897", "name": "Cytochrome P450 - arranged by substrate type"}, {"id": "R-HSA-211945", "name": "Phase I - Functionalization of compounds"}, {"id": "R-HSA-211979", "name": "Eicosanoids"}, {"id": "R-HSA-2142753", "name": "Arachidonic acid metabolism"}, {"id": "R-HSA-2162123", "name": "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}, {"id": "R-HSA-8978868", "name": "Fatty acid metabolism"}], "smpdb": [{"id": "SMP00075", "name": "Arachidonic Acid Metabolism"}, {"id": "SMP00077", "name": "Piroxicam Action Pathway"}, {"id": "SMP00083", "name": "Acetylsalicylic Acid Action Pathway"}, {"id": "SMP00084", "name": "Etodolac Action Pathway"}, {"id": "SMP00085", "name": "Ketoprofen Action Pathway"}, {"id": "SMP00086", "name": "Ibuprofen Action Pathway"}, {"id": "SMP00087", "name": "Rofecoxib Action Pathway"}, {"id": "SMP00093", "name": "Diclofenac Action Pathway"}, {"id": "SMP00094", "name": "Sulindac Action Pathway"}, {"id": "SMP00096", "name": "Celecoxib Action Pathway"}, {"id": "SMP00098", "name": "Ketorolac Action Pathway"}, {"id": "SMP00101", "name": "Suprofen Action Pathway"}, {"id": "SMP00102", "name": "Bromfenac Action Pathway"}, {"id": "SMP00104", "name": "Indomethacin Action Pathway"}, {"id": "SMP00106", "name": "Meloxicam Action Pathway"}, {"id": "SMP00109", "name": "Mefenamic Acid Action Pathway"}, {"id": "SMP00113", "name": "Oxaprozin Action Pathway"}, {"id": "SMP00114", "name": "Nabumetone Action Pathway"}, {"id": "SMP00116", "name": "Valdecoxib Action Pathway"}, {"id": "SMP00120", "name": "Naproxen Action Pathway"}, {"id": "SMP00289", "name": "Diflunisal Action Pathway"}, {"id": "SMP00353", "name": "Leukotriene C4 Synthesis Deficiency"}, {"id": "SMP00692", "name": "Antipyrine Action Pathway"}, {"id": "SMP00693", "name": "Antrafenine Action Pathway"}, {"id": "SMP00694", "name": "Carprofen Action Pathway"}, {"id": "SMP00695", "name": "Etoricoxib Action Pathway"}, {"id": "SMP00696", "name": "Fenoprofen Action Pathway"}, {"id": "SMP00697", "name": "Flurbiprofen Action Pathway"}, {"id": "SMP00698", "name": "Magnesium salicylate Action Pathway"}, {"id": "SMP00699", "name": "Lumiracoxib Action Pathway"}, {"id": "SMP00700", "name": "Lornoxicam Action Pathway"}, {"id": "SMP00701", "name": "Phenylbutazone Action Pathway"}, {"id": "SMP00702", "name": "Nepafenac Action Pathway"}, {"id": "SMP00703", "name": "Trisalicylate-choline Action Pathway"}, {"id": "SMP00704", "name": "Tolmetin Action Pathway"}, {"id": "SMP00705", "name": "Tiaprofenic Acid Action Pathway"}, {"id": "SMP00706", "name": "Tenoxicam Action Pathway"}, {"id": "SMP00707", "name": "Salsalate Action Pathway"}, {"id": "SMP00708", "name": "Salicylate-sodium Action Pathway"}, {"id": "SMP00709", "name": "Salicylic Acid Action Pathway"}, {"id": "SMP00710", "name": "Acetaminophen  Action Pathway"}], "wikipathways": [{"id": "WP167", "name": "Eicosanoid Synthesis"}, {"id": "WP236", "name": "Adipogenesis"}, {"id": "WP4719", "name": "Eicosanoid metabolism via cyclooxygenases (COX)"}, {"id": "WP98", "name": "Prostaglandin Synthesis and Regulation"}]}, "pdb": ["2IAG", "3B6H"], "pfam": "PF00067", "pharmgkb": "PA292", "pharos": {"target_id": 15914, "tdl": "Tchem"}, "pir": "JC2231", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF255131", "relationship": "is"}, {"id": "GNF255132", "relationship": "is"}, {"id": "GNF255133", "relationship": "is"}, {"id": "GNF255134", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF088105", "relationship": "is"}, {"id": "GNF088106", "relationship": "is"}, {"id": "GNF088107", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051308", "relationship": "is"}, {"id": "GNF056074", "relationship": "is"}, {"id": "GNF060789", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF067775", "relationship": "is"}, {"id": "GNF067776", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF094007", "relationship": "is"}, {"id": "GNF133665", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000020.11", "NC_060944.1", "NG_007940.1"], "protein": ["NP_000952.1", "XP_047296281.1", "XP_054179732.1"], "rna": ["NM_000961.4", "XM_047440325.1", "XM_054323757.1"], "translation": [{"protein": "XP_047296281.1", "rna": "XM_047440325.1"}, {"protein": "NP_000952.1", "rna": "NM_000961.4"}, {"protein": "XP_054179732.1", "rna": "XM_054323757.1"}]}, "reporter": {"HG-U133_Plus_2": ["208131_s_at", "210702_s_at", "211892_s_at"], "HG-U95Av2": ["36533_at", "759_at"], "HTA-2_0": "TC20000927.hg.1", "HuEx-1_0": "3908934", "HuGene-1_1": "8066925", "HuGene-2_1": "16920156"}, "summary": "This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. However, this protein is considered a member of the cytochrome P450 superfamily on the basis of sequence similarity rather than functional similarity. This endoplasmic reticulum membrane protein catalyzes the conversion of prostglandin H2 to prostacyclin (prostaglandin I2), a potent vasodilator and inhibitor of platelet aggregation. An imbalance of prostacyclin and its physiological antagonist thromboxane A2 contribute to the development of myocardial infarction, stroke, and atherosclerosis. [provided by RefSeq, Jul 2008].", "symbol": "PTGIS", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1419071"}, "unigene": "Hs.302085", "uniprot": {"Swiss-Prot": "Q16647"}, "wikipedia": {"url_stub": "Prostacyclin synthase"}}